Table 3 |
||||||||
|
Examples of recent mouse gene duplications |
||||||||
| Locus1* |
Gene |
Percent identity† |
Annotation |
Locus2* |
Gene |
Percent identity† |
Annotation |
Duplication % identity‡ |
|
|
||||||||
| 1 F |
NM_009888 |
99.6 |
Cfh (Complement component factor h) |
1 F |
M29010 |
99.0 |
Complement factor H-related protein mRNA |
97.1 |
| 3 G1 |
NM_009669 |
100 |
Amy2 (Amylase 2, pancreatic) |
3 G1 |
M11896 |
99.6 |
Pancreatic amylase B-1 |
97.6 |
| 5 E2 |
NM_053184 |
99.9 |
Ugt2a1 (UDP glycosyltransferase 2 A1) |
5 E2 |
BF144793 |
99.6 |
cDNA clone IMAGE:4021939 |
95.7 |
| 5 E2 |
NM_009467 |
100 |
Ugt2b5(UDP-glucuronosyl-transferase 2b5) |
5 E2 |
NM_053215 |
100 |
RIKEN cDNA 0610033E06 gene |
93.3 |
| 5 E4 |
NM_008620 |
99.9 |
Mpa2 (macrophage activation 2) |
5 E4 |
BC007143 |
99.5 |
Similar to macrophage activation 2 |
90.6 |
| 5 G1 |
NM_029693 |
100 |
RIKEN cDNA 1700123K08 |
7 B2 |
NM_027702 |
100 |
RIKEN cDNA 4933421I07 gene |
91.1 |
| 6 C1 |
NM_053238 |
100 |
V1rc8 (Vomeronasal 1 receptor, C8) |
6 C1 |
NM_053239 |
99.7 |
V1rc9 (Vomeronasal 1 receptor, C9) |
95.1 |
| 6 D1 |
NM_011467 |
99.9 |
Spr (sepiapterin reductase) |
6 D1 |
BE862957 |
99.5 |
EST sequence |
95.8 |
| 6 F1 |
AI505330 |
100 |
Similar to initiation factor eIF-4AI |
6 F1 |
AI503670 |
99.8 |
Similar to initiation factor eIF-4AI |
98.9 |
| 6 F2 |
NM_008646 |
99.9 |
Mug2 (Murinoglobulin 2) |
6 F2 |
NM_008645 |
99.9 |
Mug1 (Murinoglobulin 1) |
94.6 |
| 6 F3 |
NM_020257 |
99.8 |
Dcl1 (c-type lectin 1) |
6 F3 |
NM_027562 |
99.9 |
4632413B12Rik (C-lectin related protein) |
90.8 |
| 6 F3 |
NM_008463 |
99.7 |
Klra5 (Killer cell lectin-like receptor, A5) |
6 F3 |
NM_008464 |
99.5 |
Klra6 (Killer cell lectin-like receptor, A6) |
90.0 |
| 6 F3 |
NM_010649 |
99.8 |
Klra4 (Killer cell lectin-like receptor A4) |
6 F3 |
NM_016659 |
99.8 |
Klra1 (Killer cell lectin-like receptor A1) |
91.4 |
| 6 F3 |
NM_010737 |
99.8 |
Klrb1b (Killer cell lectin-like receptor 1b) |
6 F3 |
NM_008527 |
99.9 |
Klrb1c (Killer cell lectin-like receptor 1c) |
90.8 |
| 7 A2 |
NM_011860 |
100 |
Mater (Maternal effect gene) |
7 A1 |
AK016782 |
100 |
Similar to Mater protein |
96.6 |
| 7 B1 |
NM_032541 |
100 |
Hamp hepcidin antimicrobial peptide |
7 B1 |
AK007975 |
99.8 |
Prohepcidin homolog |
92.8 |
| 7 B2 |
NM_010115 |
99 |
Klk13 (Kallikrein 13) |
7 B2 |
NM_008454 |
99.9 |
Klk16 (Kallikrein 16) |
92.2 |
| 8 D1 |
L11333 |
99.9 |
Carboxylesterase |
8 D1 |
NM_144511 |
100 |
Es31 |
95.2 |
| 9 F4 |
NM_130864 |
99.6 |
Acaa acetyl-Coenzyme A acyltransferase |
9 F4 |
BC019882 |
100 |
Similar to acetyl-CoA acyltransferase |
96.6 |
| 10 B3 |
NM_013532 |
99.9 |
Gp49a (Glycoprotein 49A) |
10 B3 |
NM_008147 |
100 |
Gp49b (glycoprotein 49B) |
96.7 |
| 10 D2 |
NM_017372 |
100 |
Lyzs (Lysozyme) |
10 D2 |
NM_013590 |
99.8 |
Lzp-s (P lysozyme structural) |
95.3 |
| 11 A3.2 |
NM_172792 |
100 |
hypothetical protein 4932414J04 |
17 D |
AK03001 |
100 |
Tyrosine protein kinase/cysteine-rich region |
94.0 |
| 11 B1.3 |
NM_011396 |
99.9 |
Slc22a5 (Solute carrier family 22) |
11 B1.3 |
NM_019723 |
100 |
Slc22a9 (solute carrier family 22) |
91.2 |
| 11 D |
NM_021347 |
100 |
Gsdm (Gasdermin) |
11 D |
NM_029727 |
99.9 |
2200001G21Rik |
94.2 |
| 12 F1 |
BC002065 |
99.6 |
Serine protease inhibitor 2-1 |
12 F1 |
BY761363 |
99.9 |
EST sequence |
92.2 |
| 12 F1 |
NM_013772 |
100 |
Tcl1b3 (T-cell leukemia/lymphoma 1B, 3) |
12 F1 |
NM_013776 |
100 |
Tcl1b5 (T-cell leukemia/lymphoma 1B, 5) |
95.3 |
| 13 A1 |
NM_013778 |
99.5 |
Akr1c13 (Aldo-keto reductase 1, C13) |
13 A1 |
NM_013777 |
99.5 |
Akrc12 (Aldo-keto reductase 1, C12) |
96.1 |
| 13 A3 |
NM_008864 |
99.2 |
Csh1 (chorionic somatomammotrophin 1) |
13 A3.3 |
AK082929 |
100 |
Similar to placental lactogen 1 |
98.8 |
| 13 A4 |
NM_011456 |
100 |
Spi14 (Serine Protease Inhibitor 14) |
13 A4 |
NM_011455 |
100 |
Spi13 (serine protease inhibitor 13) |
95.2 |
| 13 D1 |
NM_010872 |
100 |
Birc1b (Neuronal apoptosis inhibitory 2) |
13 D1 |
NM_008670 |
99.9 |
Birc1a (Neuronal apoptosis inhibitory 1) |
90.0 |
| 14 C1 |
NM_010373 |
99.7 |
Gzme (Granzyme E) |
14 C1 |
NM_010372 |
99.9 |
Gzmd (Granzyme D) |
94.7 |
| 14 C2 |
NM_172603 |
100 |
4933417L10Rik |
14 C3 |
BE381578 |
100 |
EST sequence |
94.0 |
| 15 E2 |
NM_007781 |
100 |
Csf2rb2 (Colony stimulating factor 2, β-2) |
15 E2 |
NM_007780 |
99.8 |
Csf2rb1 (Colony stimulating factor 2, β-1) |
95.0 |
| 15 E2 |
NM_010005 |
100 |
Cyp2d10 (Cytochrome P450, 2d10) |
15 E2 |
NM_010006 |
100 |
Cyp2d9 (cytochrome P450, 2d9) |
92.1 |
| 16 B1 |
NM_023125 |
100 |
Kng (Kininogen) |
16 B1 |
BI330914 |
99.1 |
EST sequence |
90.0 |
| 16 B3 |
M92418 |
99.8 |
MS2 (Cysteine proteinase inhibitor) |
16 B3 |
BB654253 |
100 |
EST sequence |
95.2 |
| 17 B2 |
NM_009780 |
99.9 |
C4 (Complement component 4) |
17 B2 |
M21576 |
99.5 |
Slp (MHC sex-limited protein) |
96.3 |
| X A2 |
NM_008955 |
100 |
Psx1 (Placenta specific homeobox 1) |
X A2 |
NM_023894 |
100 |
Homeobox protein GPBOX |
91.6 |
|
|
||||||||
|
*Locations of duplicons by mouse chromosome banding; locus 1 and 2 represent a duplication pair. †Alignment percent identity between gene and genomic sequences showing correct matches. ‡ % similarity: average DNA percent identity between paralogous gene/transcript sequences in locus 1 and 2 (duplicated pair) |
||||||||
|
Cheung et al. Genome Biology 2003 4:R47 doi:10.1186/gb-2003-4-8-r47 |
||||||||